Ergomed interim results webinar 19th September, 12:45pm

The management of Ergomed (AIM:ERGO.L), which offers clinical trials and pharmacovigilance services to pharmaceutical companies, while also co-developing a product portfolio of therapies, would like to invite you to a presentation of their interim results.

Dr Dan Weng, Chief Executive Officer, and Stephen Stamp, Chief Financial Officer, will give a presentation lasting approximately 30 mins and there will then be an opportunity for Q&A. If you would like to join please register now:

Register here.

After registering, you will receive a confirmation email containing information about joining the webinar.

If you would like to submit any questions for management ahead of the meeting please send them to [email protected]